These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10362643)

  • 1. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones.
    Xiao ZL; Chen Q; Amaral J; Biancani P; Jensen RT; Behar J
    Am J Physiol; 1999 Jun; 276(6):G1401-7. PubMed ID: 10362643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility.
    Xiao Z; Schmitz F; Pricolo VE; Biancani P; Behar J
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1641-9. PubMed ID: 17307729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones.
    Xiao ZL; Chen Q; Amaral J; Biancani P; Behar J
    Am J Physiol Gastrointest Liver Physiol; 2000 Feb; 278(2):G251-8. PubMed ID: 10666049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
    Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity.
    Chen Q; Amaral J; Biancani P; Behar J
    Gastroenterology; 1999 Mar; 116(3):678-85. PubMed ID: 10029627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol trisphosphate restores impaired human gallbladder motility associated with cholesterol stones.
    Behar J; Rhim BY; Thompson W; Biancani P
    Gastroenterology; 1993 Feb; 104(2):563-8. PubMed ID: 8425698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different pathways mediate cholecystokinin actions in cholelithiasis.
    Chen Q; De Petris G; Yu P; Amaral J; Biancani P; Behar J
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G838-44. PubMed ID: 9142916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallbladder muscle dysfunction in patients with chronic acalculous disease.
    Amaral J; Xiao ZL; Chen Q; Yu P; Biancani P; Behar J
    Gastroenterology; 2001 Feb; 120(2):506-11. PubMed ID: 11159891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones.
    Yu P; Chen Q; Harnett KM; Amaral J; Biancani P; Behar J
    Am J Physiol; 1995 Nov; 269(5 Pt 1):G659-65. PubMed ID: 7491956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder relaxation in patients with pigment and cholesterol stones.
    Chen Q; Amaral J; Oh S; Biancani P; Behar J
    Gastroenterology; 1997 Sep; 113(3):930-7. PubMed ID: 9287986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA synthesis index: higher for human gallbladders with cholesterol gallstones than with pigment gallstones.
    Lamote J; Putz P; Francois M; Willems G
    J Natl Cancer Inst; 1983 Sep; 71(3):449-53. PubMed ID: 6577219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
    Kano M; Shoda J; Satoh S; Kobayashi M; Matsuzaki Y; Abei M; Tanaka N
    J Lab Clin Med; 2002 May; 139(5):285-94. PubMed ID: 12032489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle.
    Cong P; Pricolo V; Biancani P; Behar J
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G742-50. PubMed ID: 20558763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH; Portincasa P; Wang DQ
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral cholecystokinin receptors in chickens differ from those in mammals.
    Rodríguez-Sinovas A; Fernández AG; Goñalons E
    Regul Pept; 1995 Dec; 60(1):47-54. PubMed ID: 8747783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle.
    Morton MF; Harper EA; Tavares IA; Shankley NP
    Br J Pharmacol; 2002 Jul; 136(6):873-82. PubMed ID: 12110612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro contractility of the musculature of human gallbladders with and without gallstones--relevance of the prostaglandin system for CCK regulated motoricity].
    Schulz M; Hanisch E; Güldütüna S
    Z Gastroenterol; 1993 Jun; 31(6):376-87. PubMed ID: 8212754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin content in gallbladders with brown pigment stones or combination stones with a brown periphery.
    Sheen PC; Lee KT; Liu YE
    Digestion; 1998; 59(6):660-4. PubMed ID: 9813390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder contraction in patients with pigment and cholesterol stones.
    Behar J; Lee KY; Thompson WR; Biancani P
    Gastroenterology; 1989 Dec; 97(6):1479-84. PubMed ID: 2583414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct contractile response of isolated gallbladder smooth muscle cells to cholecystokinin in patients with gallstones.
    Chijiiwa K; Yamasaki T; Chijiiwa Y
    J Surg Res; 1994 May; 56(5):434-8. PubMed ID: 8170143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.